SOURCE: Leerink Swann

June 04, 2007 08:00 ET

Leerink Swann Appoints Steve Weiss as Senior Managing Director and Head of Institutional Sales

BOSTON, MA--(Marketwire - June 4, 2007) - Healthcare investment bank Leerink Swann announced that Steve Weiss has joined the firm as Senior Managing Director and Head of Institutional Sales.

Mr. Weiss was most recently Co-founder and Managing Member of Short Hill Capital Partners, LLC.

Over more than twenty years, Mr. Weiss' career in institutional equities includes some of the most prestigious firms on Wall Street. For five years, he served as Managing Director and Head of U.S. Cash Sales for Lehman Brothers, where he led a 125-person team selling U.S. Research Product, as well as the distribution of non-dollar product in the U.S. Prior to that, Mr. Weiss was Global and U.S. Research Product Manager for Salomon Brothers, responsible for content, creativity and quality of product. Mr. Weiss began his career as an institutional salesperson for Oppenheimer & Company and later at Salomon Brothers. Mr. Weiss also worked in a senior management capacity at SAC Capital, LLC and was a tax attorney before entering the securities industry.

"We are delighted to have Steve Weiss join the Firm," said Jeffrey A. Leerink, Chairman and CEO of Leerink Swann. "Steve has outstanding experience leading sales teams and finding innovative ways to add value to clients. With our exclusive focus on healthcare and award-winning sales team, Steve's management and leadership will be invaluable as we strive to become the premier healthcare investment bank on Wall Street."

Leerink Swann's focused, healthcare salesforce is consistently recognized for its performance in a number of industry polls and awards. In the 2007 Greenwich Associates survey, Leerink Swann ranked #1in Best Professional Sales Support and Most Intensive Service within the healthcare category. For each of the past four years, Institutional Investor has ranked Leerink Swann's salesforce among the top five in healthcare, earning the #3 spot in 2006.

About Leerink Swann

Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, asset management, and strategic advisory services for institutional, life sciences, and high-net-worth clients. For the past six years, Institutional Investor has named Leerink Swann "Best of the Boutiques" in Biotechnology, Healthcare Technology & Distribution, Medical Supplies and Devices, Pharmaceuticals/Major, and Pharmaceuticals/Specialty. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member NASD/SIPC.

Contact Information